As of Sep 21
| -0.71 / -1.99%|
The 10 analysts offering 12-month price forecasts for Medicines Co have a median target of 51.00, with a high estimate of 85.00 and a low estimate of 43.00. The median estimate represents a +45.92% increase from the last price of 34.95.
The current consensus among 9 polled investment analysts is to Buy stock in Medicines Co. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.